ReviewDiabetes & metabolism journal2022

New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins.

Kyuho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.